T-cell Lymphoma – How Should I Use New Agents in My Practice?


Upon viewing this session, you will be able to:
• Review standard treatment options in the front-line setting for PTCL and discuss when to consider novel regimens
• Review the options for treatment of relapsed/refractory PTCL including agents or regimens in development


  • Neha Mehta-Shah, MD, Washington University in St. Louis


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top